Centre Hospitalier Groupe Hospitalier De La Rochelle Re Aunis

Clinical trials in cardiovascular diseases focus on conditions such as coronary artery disease, acute coronary syndrome, atrial fibrillation, heart failure, and myocardial infarction. The research is aimed at improving treatment strategies, preventing complications, and testing new approaches to heart and blood vessel care.

• Studies on heart rhythm problems, including out-of-hospital cardiac arrest and frequent premature ventricular contractions
• Trials in heart failure, hypertension, and atherosclerotic disease
• Research on better prevention of thromboembolism and bleeding-related treatment decisions

This area reflects a strong focus on practical improvements in diagnosis, prevention, and long-term management of cardiovascular risk.

The site is active in hematology and oncology, with trials involving multiple myeloma, diffuse large B-cell lymphoma, B-cell lymphoma, and chronic myeloid leukemia. These studies are designed to evaluate new treatment combinations, compare therapies, and improve outcomes for patients with blood cancers.

• Research in multiple myeloma, including newly diagnosed and relapsed disease
• Studies in lymphoma and other hematologic malignancies
• Trials testing whether newer approaches can improve response and disease control

This research supports more effective and better-tolerated treatment options for complex blood-related cancers.

Trials in immune system diseases and inflammatory disorders address conditions such as atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria, giant cell arteritis, and ANCA vasculitis. The goal is to assess new therapies, improve symptom control, and understand how to maintain remission or reduce disease activity.

• Studies in chronic skin inflammation, including atopic dermatitis and hidradenitis suppurativa
• Research on vasculitis, urticaria, and other immune-mediated conditions
• Trials focused on long-term disease control and treatment simplification

The Service Cardiologie site also contributes to broader inflammatory research where immune activity affects multiple organs and quality of life.

The research portfolio includes respiratory tract diseases, otorhinolaryngologic diseases, and eye diseases, with studies in chronic rhinosinusitis, uveitis, and related inflammatory conditions. These trials aim to test therapies that may reduce symptoms, protect vision, and improve disease control.

• Studies of uveitis linked to Behçet’s disease
• Research in sinus inflammation and chronic upper airway disease
• Trials exploring new options for difficult-to-treat inflammatory eye and airway disorders

This area highlights efforts to improve care for conditions that can strongly affect daily comfort and function.

The site participates in neoplasm studies spanning breast cancer, lung cancer, esophageal cancer, colon cancer, and rectal cancer. These trials are designed to compare treatment effectiveness, evaluate new immunotherapy or chemotherapy approaches, and improve outcomes in both advanced and earlier-stage disease.

• Trials in metastatic breast cancer and non-small cell lung cancer
• Research on esophageal and colorectal cancers
• Studies assessing whether newer treatment combinations can extend survival or delay progression

This cancer research reflects a broad effort to refine treatment choices across several major solid tumors.

Clinical trials also address kidney disease, venous thromboembolism, deep vein thrombosis, pulmonary embolism, and recovery after intensive care. The purpose of this work is to improve prevention of clotting events, support organ recovery, and reduce complications after severe illness.

• Studies in patients with end-stage renal disease and kidney-related complications
• Research on preventing venous thromboembolism after trauma or immobilization
• Trials focused on outcomes after ICU discharge and post-critical illness recovery

These studies aim to guide safer, more effective care for patients at high risk of vascular and renal complications.

The site contributes to studies in musculoskeletal diseases and skin and connective tissue diseases, including chronic venous ulcers, dermatitis, and hidradenitis-related conditions. Research here is centered on improving wound healing, reducing inflammation, and testing new supportive treatments for persistent skin and tissue problems.

• Trials for non-healing venous leg ulcers
• Research on chronic inflammatory skin disease and tissue repair
• Studies aiming to improve healing and symptom relief in resistant cases

This field combines practical wound care with research into better long-term management of chronic skin disease.

A smaller but important part of the portfolio includes behavior and behavior mechanisms, with studies focused on smoking cessation. These trials evaluate ways to help smokers quit and reduce the health risks linked to tobacco use.

• Research comparing different approaches to smoking cessation
• Studies aimed at supporting behavior change in adults who smoke regularly
• Trials designed to improve long-term quitting success and cardiovascular risk reduction

This work complements the site’s broader disease-focused research by addressing a major preventable risk factor.